Carisma Therapeutics, Inc. (CARM)
NASDAQ: CARM · Real-Time Price · USD
0.862
-0.005 (-0.54%)
At close: Nov 20, 2024, 4:00 PM
0.870
+0.007 (0.83%)
Pre-market: Nov 21, 2024, 6:20 AM EST
Carisma Therapeutics Employees
Carisma Therapeutics had 107 employees as of December 31, 2023.
Employees
107
Change
n/a
Growth
n/a
Revenue / Employee
$189,421
Profits / Employee
-$596,262
Market Cap
36.01M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 107 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| RAPT Therapeutics | 131 |
| Beyond Air | 107 |
| NextCure | 82 |
| Lumos Pharma | 33 |
| Incannex Healthcare | 9 |
| CERo Therapeutics Holdings | 9 |
| Eterna Therapeutics | 8 |
| Lexaria Bioscience | 5 |
CARM News
- 4 days ago - Carisma Therapeutics Presents Promising New Preclinical Data on Engineered Macrophages for the Treatment of Liver Fibrosis at AASLD The Liver Meeting® 2024 - PRNewsWire
- 13 days ago - Carisma Unveils Promising Pre-Clinical Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma - PRNewsWire
- 14 days ago - Carisma Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights - PRNewsWire
- 15 days ago - Carisma Therapeutics to Present New Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma at SITC 2024 - PRNewsWire
- 21 days ago - Carisma Therapeutics Announces Changes to its Board of Directors - PRNewsWire
- 6 weeks ago - Carisma Therapeutics Announces Upcoming Presentations at SITC 2024 - PRNewsWire
- 2 months ago - Carisma and Moderna Expand Collaboration to Develop Two In Vivo CAR-M Therapies for Autoimmune Diseases - PRNewsWire
- 2 months ago - Carisma Therapeutics to Present at Upcoming Conferences - PRNewsWire